A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer (NCT03706365)

🧪 Interventions in This Study

• Abemaciclib (DRUG)
• Placebo (DRUG)
• Abiraterone acetate (DRUG)
• Prednisone (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (112 Sites)

Showing the first 25 of 112 sites.

• St. Joseph's Hospital and Medical Center — Phoenix, Arizona
• Mayo Clinic in Arizona - Phoenix — Phoenix, Arizona
• The University of Arizona Cancer Center - North Campus — Tucson, Arizona
• St. Bernards Medical Center — Jonesboro, Arkansas
• CBCC Global Research, Inc. — Bakersfield, California
• Providence St. Jude Medical Center — Fullerton, California
• Moores Cancer Center — La Jolla, California
• TRIO-US (Translational Research in Oncology-US) — Los Angeles, California
• UCLA Hematology/Oncology - Westwood (Building 100) — Los Angeles, California
• Pacific Cancer Care — Monterey, California
• Sansum Clinic_Kendle — Santa Barbara, California
• Rocky Mountain Cancer Center — Lone Tree, Colorado
• Millennium Oncology - Hollywood — Hollywood, Florida
• Northside Hospital — Atlanta, Georgia
• Fort Wayne Medical Oncology And Hematology at Parkview Comprehensive Cancer Center — Fort Wayne, Indiana
• Massachusetts General Hospital — Boston, Massachusetts
• M Health Fairview University of Minnesota Medical Center - East Bank — Minneapolis, Minnesota
• Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
• New York Oncology Hematology (NYOH) - Clifton Park Cancer Center — Albany, New York
• Associated Medical Professionals - Urology — Syracuse, New York
• Research Medical Center — Nashville, Tennessee
• Baylor Scott & White Medical Center - Temple — Temple, Texas
• New York Oncology Hematology (NYOH) - Clifton Park Cancer Center — The Woodlands, Texas
• Northwest Cancer Specialists PC — The Woodlands, Texas
• Sansum Clinic_Kendle — The Woodlands, Texas

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Prostate Cancer

• A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC — Homewood, Alabama
• A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described — Homewood, Alabama
• Stereotactic Ablative Radiation Therapy for Prostate Cancer — Charleston, South Carolina
• A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer — Basking Ridge, New Jersey
• Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer — Baltimore, Maryland

Explore by condition: All Prostate Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.